Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Evidence-Based Medicine Center, Fudan University, Shanghai, China.
Int J Rheum Dis. 2024 Oct;27(10):e15360. doi: 10.1111/1756-185X.15360.
Takayasu arteritis (TAK) and giant cell arteritis (GCA) are two major large vessel vasculitis, with varied epidemiology by geographical location, age, and race. However, the epidemiological data in Chinese population is rarely reported. This study estimated the epidemiology of TAK and GCA in Shanghainese individuals residing in China over a 10-year period.
TAK data for individuals over 16 years and GCA data for individuals over 50 years were retrieved from 38 comprehensive hospitals in Shanghai, China through the electronic medical record systems between January 1, 2011, and December 31, 2020. A systematic literature review was performed to determine the global distribution of TAK and GCA by searching PubMed, Ovid-Medline, Excerpta Medica Database (EMBASE), and Web of Science.
In 173 identified TAK cases (67% females; mean age, 46 ± 15 years), the period prevalence was 11.72 cases per million, and the mean annual incidence was 1.33 cases per million. The highest prevalence (17.74 cases per million) and incidence (1.71 cases per million) were observed in the 16- to 34-year-old age group. In 92 identified GCA cases (56% females; age, >50 years), the period prevalence was 2.73 cases per 100 000 persons, and the mean annual incidence was 1.91 cases per 100 000 persons. Meta-analysis of the incidence study of TAK and GCA showed that the pooled incidence rate of TAK and GCA was 1.29 per million and 15.48 per 100 000 person-years, respectively. Subgroup analysis showed that the incidence of TAK was significantly higher in Asia than in other regions, while the incidence of GCA was higher in Europe, especially North Europe.
The epidemiological patterns of TAK and GCA were comprehensively mapped globally and locally, in Shanghai, China.
Takayasu 动脉炎(TAK)和巨细胞动脉炎(GCA)是两种主要的大血管血管炎,其在地理位置、年龄和种族方面的流行病学特征各不相同。然而,中国人群的流行病学数据很少有报道。本研究估计了 10 年间居住在中国上海的人群中 TAK 和 GCA 的流行病学情况。
通过电子病历系统,从中国上海的 38 家综合医院中检索了年龄在 16 岁以上的 TAK 患者数据和年龄在 50 岁以上的 GCA 患者数据,检索时间范围为 2011 年 1 月 1 日至 2020 年 12 月 31 日。通过检索 PubMed、Ovid-Medline、Excerpta Medica Database(EMBASE)和 Web of Science,进行了一项系统的文献综述,以确定 TAK 和 GCA 的全球分布情况。
在 173 例确诊的 TAK 病例中(67%为女性;平均年龄为 46±15 岁),现患率为 11.72/100 万,年平均发病率为 1.33/100 万。发病率和现患率最高的年龄段为 16-34 岁(分别为 17.74/100 万和 1.71/100 万)。在 92 例确诊的 GCA 病例中(56%为女性;年龄>50 岁),现患率为 2.73/10 万,年平均发病率为 1.91/10 万。TAK 和 GCA 发病率研究的荟萃分析显示,TAK 和 GCA 的合并发病率分别为 1.29/100 万和 15.48/10 万。亚组分析显示,TAK 的发病率在亚洲明显高于其他地区,而 GCA 的发病率在欧洲,尤其是北欧较高。
本研究全面绘制了 TAK 和 GCA 的全球和局部流行病学图谱,包括在中国上海。